CYPH CYPHERPUNK TECHNOLOGIES INC.

$0.74 -3.70%

Healthcare · Pharmaceutical Preparations

CYPHERPUNK TECHNOLOGIES INC. (CYPH) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $79 million. Shares last traded at $0.74, 80.6% below their 52-week high. CYPH trades at a price-to-earnings ratio of 15.74, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 333.3%, above the peer median of -0.1%. Revenue grew 0.0% year over year.

Market Cap

$79M

Shares Out

106.5M

EPS (TTM)

$-2.46

P/E Ratio

15.74

P/S Ratio

52.47

P/B Ratio

0.93

Dividend / Share

—

Dividend Yield

—

52-Week High

$3.82

52-Week Low

$0.49

Volume

69,446

Avg Vol (3m)

138,536.778

Performance

+8.32%

-31.86%

+3.38%

-38.39%

YTD

-34.58%

—

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

43.71

SMA (50)

$0.98

SMA (200)

—

Price vs SMA50

-24.55%

Price vs SMA200

—

ATR (14)

$0.15

Financials

Revenue

$2M

Net Income

$5M

Gross Margin

—

Operating Margin

-2737.8%

Net Margin

333.3%

Return on Equity

5.9%

Return on Assets

5.7%

Current Ratio

27.28

Debt / Equity

0.04

Revenue Growth (YoY)

+0.0%

Latest reported annual period ending 2021-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.46	2026-05-14
FY 2025	$0.07	2026-03-16
Q3 2025	$-0.85	2025-11-12
Q2 2025	$-0.78	2025-08-14
Q1 2026	$-0.37	2026-05-14
FY 2025	$-1.81	2026-03-16

Full earnings history →

Pharmaceutical Preparations peers

CYPH vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

15.74 / 16.82 med

-6% discount

P/S vs peers

52.47 / 3.54 med

+1383% premium

Net margin vs peers

333.3% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.